Integrin α11β1 has been shown to promote tumor growth and metastatic potential of non-small cell lung cancer (NSCLC) cells (Navab et al., 2016), breast cancer, in conjunction with platelet-derived growth factor receptor β (PDGFRβ) (Primac et al., 2019), and in head and neck squamous cell carcinoma (HNSCC) and pancreatic ductal adenocarcinoma (PDAC) (Zeltz et al., 2019). Here, PDGFRB is linked to non-small cell lung carcinoma.